Use of Somatropin in Turner Syndrome

• Status: Completed
• Trial end date: 2004-04-11

Summary

This trial is conducted in Europe. The aim of this trial is to study the dose-response relationship and effect of somatropin (Norditropin®) on final height in girls with Turner Syndrome.

• Phase: Phase 3

Details

• Lead Sponsor: Novo Nordisk A/S